Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Array-based DNA methylation profiling for breast cancer subtype discrimination.

Van der Auwera I, Yu W, Suo L, Van Neste L, van Dam P, Van Marck EA, Pauwels P, Vermeulen PB, Dirix LY, Van Laere SJ.

PLoS One. 2010 Sep 7;5(9):e12616. doi: 10.1371/journal.pone.0012616.

2.

Is there a role for mammary stem cells in inflammatory breast carcinoma?: a review of evidence from cell line, animal model, and human tissue sample experiments.

Van Laere S, Limame R, Van Marck EA, Vermeulen PB, Dirix LY.

Cancer. 2010 Jun 1;116(11 Suppl):2794-805. doi: 10.1002/cncr.25180. Review.

3.

Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients.

Van der Auwera I, Bovie C, Svensson C, Trinh XB, Limame R, van Dam P, van Laere SJ, van Marck EA, Dirix LY, Vermeulen PB.

BMC Cancer. 2010 Mar 12;10:97. doi: 10.1186/1471-2407-10-97.

4.

Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.

Van den Eynden GG, Van Laere SJ, Van der Auwera I, Trinh XB, Van Marck EA, Dirix LY, Vermeulen PB.

Int J Cancer. 2009 Sep 15;125(6):1494-6. doi: 10.1002/ijc.24524. No abstract available.

5.

A 61-year-old female patient with right-sided pleuritic chest pain and fatigue. Diagnosis: Inflammatory pseudotumour causing right pulmonary artery occlusion with subsequent infarction of the lung.

Messaoudi N, De Cocker J, Van den Eynden G, Janssens A, Salgado RA, Van Marck EA, Van Schil PE.

Eur Respir J. 2009 May;33(5):1231-5. doi: 10.1183/09031936.00091808. No abstract available.

6.

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients.

Van der Auwera I, Elst HJ, Van Laere SJ, Maes H, Huget P, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.

Br J Cancer. 2009 Apr 21;100(8):1277-86. doi: 10.1038/sj.bjc.6605013.

7.

Fibrous intimal thickening at implantation adversely affects long-term kidney allograft function.

Woestenburg AT, Verpooten GA, Ysebaert DK, Van Marck EA, Verbeelen D, Bosmans JL.

Transplantation. 2009 Jan 15;87(1):72-8. doi: 10.1097/TP.0b013e31818bbe06.

PMID:
19136894
8.

Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype.

Van der Auwera I, Van Laere SJ, Van den Bosch SM, Van den Eynden GG, Trinh BX, van Dam PA, Colpaert CG, van Engeland M, Van Marck EA, Vermeulen PB, Dirix LY.

Br J Cancer. 2008 Nov 18;99(10):1735-42. doi: 10.1038/sj.bjc.6604705. Epub 2008 Oct 7.

9.

Gene expression profiles associated with the presence of a fibrotic focus and the growth pattern in lymph node-negative breast cancer.

Van den Eynden GG, Smid M, Van Laere SJ, Colpaert CG, Van der Auwera I, Bich TX, van Dam P, den Bakker MA, Dirix LY, Van Marck EA, Vermeulen PB, Foekens JA.

Clin Cancer Res. 2008 May 15;14(10):2944-52. doi: 10.1158/1078-0432.CCR-07-4397.

10.

The missing ink.

Elst PG, Meels DA, Van Marck EA, Tjalma WA.

Eur J Obstet Gynecol Reprod Biol. 2008 Oct;140(2):277-8. doi: 10.1016/j.ejogrb.2007.11.005. Epub 2007 Dec 27. No abstract available.

PMID:
18164121
11.

Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node.

Van den Eynden GG, Vandenberghe MK, van Dam PJ, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5391-7.

12.

Letter to the editor: Lymphangiogenesis in primary breast cancer.

Van den Eynden GG, Van der Auwera I, Colpaert CG, Dirix LY, Van Marck EA, Vermeulen PB.

Cancer Lett. 2007 Oct 28;256(2):279-81; author reply 283-4. Epub 2007 Aug 21. No abstract available.

PMID:
17714860
13.

NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation.

Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.

Br J Cancer. 2007 Sep 3;97(5):659-69. Epub 2007 Aug 14.

14.

Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer.

Van den Eynden GG, Van der Auwera I, Van Laere SJ, Trinh XB, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA.

J Pathol. 2007 Sep;213(1):56-64.

PMID:
17674348
15.

Correlation between laminin-5 immunohistochemistry and human papillomavirus status in squamous cervical carcinoma.

Boulet GA, Schrauwen I, Sahebali S, Horvath C, Depuydt CE, Vereecken A, Broeck DV, Van Marck EA, Bogers JJ.

J Clin Pathol. 2007 Aug;60(8):896-901.

16.

Fine needle trucut biopsy in focal liver lesions: a reliable and safe method in identifying the malignant nature of liver lesions.

De Pauw FF, Francque SM, Bogers JP, Duysburgh IK, Pelckmans PA, Van Marck EA, Michielsen PP.

Acta Gastroenterol Belg. 2007 Jan-Mar;70(1):1-5.

PMID:
17619530
17.

A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation.

Van den Eynden GG, Colpaert CG, Couvelard A, Pezzella F, Dirix LY, Vermeulen PB, Van Marck EA, Hasebe T.

Histopathology. 2007 Oct;51(4):440-51. Epub 2007 Jun 26. Review.

PMID:
17593207
18.

Epilepsy and migraine in a patient with Urbach-Wiethe disease.

Claeys KG, Claes LR, Van Goethem JW, Sercu S, Merregaert J, Lambert J, Van Marck EA, Parizel PM, De Jonghe P.

Seizure. 2007 Jul;16(5):465-8. Epub 2007 Apr 2.

19.

Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer.

Van den Eynden GG, Van Laere SJ, Van der Auwera I, Gilles L, Burn JL, Colpaert C, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB.

Clin Exp Metastasis. 2007;24(1):13-23. Epub 2007 Feb 13.

PMID:
17295094
20.

Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer.

Van den Eynden GG, Van der Auwera I, Van Laere SJ, Huygelen V, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA.

Br J Cancer. 2006 Nov 20;95(10):1362-6. Epub 2006 Oct 31.

21.

The host's genetic background determines the extent of angiogenesis induced by schistosome egg antigens.

Van de Vijver KK, Colpaert CG, Jacobs W, Kuypers K, Hokke CH, Deelder AM, Van Marck EA.

Acta Trop. 2006 Oct;99(2-3):243-51. Epub 2006 Sep 27.

PMID:
17007805
22.

Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.

Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3249-56.

23.

Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study.

Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA.

Br J Cancer. 2006 Jun 5;94(11):1643-9.

24.

LacdiNAc- and LacNAc-containing glycans induce granulomas in an in vivo model for schistosome egg-induced hepatic granuloma formation.

Van de Vijver KK, Deelder AM, Jacobs W, Van Marck EA, Hokke CH.

Glycobiology. 2006 Mar;16(3):237-43. Epub 2005 Nov 10.

PMID:
16282603
25.

Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.

Van der Auwera I, Van den Eynden GG, Colpaert CG, Van Laere SJ, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB.

Clin Cancer Res. 2005 Nov 1;11(21):7637-42.

26.

Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.

Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY.

Breast Cancer Res Treat. 2006 Feb;95(3):243-55. Epub 2005 Oct 27.

27.

Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer.

Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG, Turley H, Harris AL, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA.

Br J Cancer. 2005 Nov 14;93(10):1128-36.

28.

Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.

Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL.

Breast Cancer Res Treat. 2006 Feb;95(3):219-28. Epub 2005 Oct 22.

29.

Combined Pap and HPV testing in primary screening for cervical abnormalities: should HPV detection be delayed until age 35?

Baay MF, Tjalma WA, Lambrechts HA, Pattyn GG, Lardon F, Weyler J, Van Royen P, Van Marck EA, Vermorken JB.

Eur J Cancer. 2005 Nov;41(17):2704-8. Epub 2005 Oct 18.

PMID:
16242316
30.

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.

van Meerbeeck JP, Gaafar R, Manegold C, Van Klaveren RJ, Van Marck EA, Vincent M, Legrand C, Bottomley A, Debruyne C, Giaccone G; European Organisation for Research and Treatment of Cancer Lung Cancer Group; National Cancer Institute of Canada.

J Clin Oncol. 2005 Oct 1;23(28):6881-9.

PMID:
16192580
31.

Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis.

Van Laere S, Van der Auwera I, Van den Eynden GG, Fox SB, Bianchi F, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.

Breast Cancer Res Treat. 2005 Oct;93(3):237-46.

PMID:
16172796
32.

Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study.

Sahebali S, Depuydt CE, Boulet GA, Arbyn M, Moeneclaey LM, Vereecken AJ, Van Marck EA, Bogers JJ.

Int J Cancer. 2006 Mar 1;118(5):1254-60.

33.

Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.

Baak JP, Colpaert CG, van Diest PJ, Janssen E, van Diermen B, Albernaz E, Vermeulen PB, Van Marck EA.

Eur J Cancer. 2005 Sep;41(14):2093-101.

PMID:
16153819
34.

Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.

Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA, Vermeulen PB, Dirix LY.

Clin Cancer Res. 2004 Dec 1;10(23):7965-71.

35.

Juvenile rhesus monkeys have more colonic granulomas than adults after primary infection with Schistosoma mansoni.

Bogers JJ, Chatterjee S, Jacobs W, Fallon PG, Dunne DW, Langermans JA, Deelder AM, Thomas AW, Van Marck EA.

Virchows Arch. 2004 Sep;445(3):285-91. Epub 2004 Jul 30.

PMID:
15517371
36.

Discrimination between the anti-monomeric and the anti-multimeric Lewis X response in murine schistosomiasis.

Van Roon AM, Van de Vijver KK, Jacobs W, Van Marck EA, Van Dam GJ, Hokke CH, Deelder AM.

Microbes Infect. 2004 Nov;6(13):1125-32.

PMID:
15488731
37.

Bacillus Calmette-Guérin-induced granulomatous hepatitis in a patient with a superficial bladder carcinoma.

Van Outryve SM, Francque SM, Gentens PA, De Pauw FF, Van den Bogaert E, Van Marck EA, Pelckmans PA, Michielsen PP.

Eur J Gastroenterol Hepatol. 2004 Oct;16(10):1027-32. Review.

PMID:
15371927
38.

Glycans of Schistosoma mansoni and keyhole limpet haemocyanin induce hepatic granulomas in vivo.

van de Vijver KK, Hokke CH, van Remoortere A, Jacobs W, Deelder AM, Van Marck EA.

Int J Parasitol. 2004 Jul;34(8):951-61.

PMID:
15217734
39.

Circulating levels of the neuropeptide hormone somatostatin may determine hepatic fibrosis in Schistosoma mansoni infections.

Chatterjee S, Mbaye A, Alfidja AT, Weyler J, Scott JT, Van Damme P, Van De Vijver K, Deelder A, Van Marck EA.

Acta Trop. 2004 Apr;90(2):191-203.

PMID:
15177146
40.

Bilateral adrenal haemorrhage and acute adrenal insufficiency in a blunt abdominal trauma: a case-report and literature review.

Francque SM, Schwagten VM, Ysebaert DK, Van Marck EA, Beaucourt LA.

Eur J Emerg Med. 2004 Jun;11(3):164-7. Review.

PMID:
15167178
41.

Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes.

De Block CE, Colpin G, Thielemans K, Coopmans W, Bogers JJ, Pelckmans PA, Van Marck EA, Van Hoof V, Martin M, De Leeuw IH, Bouillon R, Van Gaal LF.

Diabetes Care. 2004 Jun;27(6):1387-93.

PMID:
15161793
42.

Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.

Stessels F, Van den Eynden G, Van der Auwera I, Salgado R, Van den Heuvel E, Harris AL, Jackson DG, Colpaert CG, van Marck EA, Dirix LY, Vermeulen PB.

Br J Cancer. 2004 Apr 5;90(7):1429-36.

43.

Treatment policy of neuroendocrine small cell cancer of the cervix.

Trinh XB, Bogers JJ, Van Marck EA, Tjalma WA.

Eur J Gynaecol Oncol. 2004;25(1):40-4. Review.

PMID:
15053060
44.

Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer.

Van den Eynden GG, Van der Auwera I, Van Laere S, Colpaert CG, van Dam P, Merajver S, Kleer CG, Harris AL, Van Marck EA, Dirix LY, Vermeulen PB.

Breast Cancer Res Treat. 2004 May;85(1):13-22.

46.

Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women.

Baay MF, Smits E, Tjalma WA, Lardon F, Weyler J, Van Royen P, Van Marck EA, Vermorken JB.

Int J Cancer. 2004 Jan 10;108(2):258-61.

47.

The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis.

Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck EA.

Breast Cancer Res Treat. 2003 Sep;81(2):137-47.

PMID:
14572156
48.

Growth index is independent of microvessel density in non-small cell lung carcinomas.

Sardari Nia P, Stessels F, Pezzella F, Vermeulen PB, van Marck EA, van Schil P.

Hum Pathol. 2003 Sep;34(9):959-60; author reply 960-1. No abstract available.

PMID:
14562297
49.

Commentary re: N. J. McCarthy et al., microvessel density, expression of estrogen receptor alpha, MIB-1, p53 and c-erbB-2 in inflammatory breast cancer. Clin. Cancer Res., 8: 3857-3862, 2002.

Colpaert CG, Vermeulen PB, Dirix LY, Van Marck EA.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3815-6; author reply 3816. No abstract available.

50.

Biopsy of focal liver lesions: guidelines, comparison of techniques and cost-analysis.

Francque SM, De Pauw FF, Van den Steen GH, Van Marck EA, Pelckmans PA, Michielsen PP.

Acta Gastroenterol Belg. 2003 Apr-Jun;66(2):160-5. Review.

PMID:
12891926

Supplemental Content

Loading ...
Support Center